TIGAR-O
| Toxic-metabolic |
|---|
| Alcoholic |
| Tobacco smoking |
| Hypercalcemia |
| Hyperlipidemia (hypertriglyceridemia) |
| Chronic renal failure |
| Idiopathic |
|---|
| Early onset |
| Late onset |
| Tropical |
| Genetic |
|---|
| Cationic trypsinogen (PRSS1) |
| Cystic fibrosis transmembrane conductance regulator gene (CFTR)a |
| Calcium-sensing receptor (CASR)a |
| Chymotrypsin C gene (CTRC)a |
| Pancreatic secretory trypsin inhibitor gene (SPINK1)a |
| Autoimmune |
|---|
| Type 1 autoimmune pancreatitis (associated with IgG4-related disease) |
| Type 2 autoimmune pancreatitis (idiopathic duct-centric chronic pancreatitis) |
| Recurrent and severe acute pancreatitis |
|---|
| Postnecrotic (severe acute pancreatitis) |
| Recurrent acute pancreatitis |
| Vascular diseases/ischemia |
| Radiation induced |
| Obstructive |
|---|
| Pancreas divisuma |
| Duct obstruction (e.g., tumor) |
| Preampullary duodenal wall cysts |
| Posttraumatic pancreatic duct strictures |